Paper Details 
Original Abstract of the Article :
Chronic toxicity studies of fenofibrate were carried out in rats (3 months), dogs (7 et 24 months) and Rhesus monkeys (12 months). The results in the last named species (78 animals) were of particular interest, since the treated monkeys had normal size liver without histological abnormalities. Elect...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/7208340

データ提供:米国国立医学図書館(NLM)

Fenofibrate: A Look at its Effects and Side Effects

This study explores the [pharmacology and toxicology] of [fenofibrate], a medication used to lower [cholesterol] levels. The researchers conducted a series of studies in [animals] to assess the long-term effects of [fenofibrate]. They found that while [fenofibrate] was generally well-tolerated, some [side effects] were observed, such as [digestive disorders, sexual fatigue, myalgia, and alopecia]. The study also explored the potential for [fenofibrate] to cause [cancer or other health problems], but no evidence was found to support this.

Navigating the Side Effects of Medications

This study highlights the importance of being aware of the potential [side effects] of medications. While [fenofibrate] can be effective in lowering [cholesterol] levels, it's important to be aware of the possible risks and discuss any concerns with your healthcare provider. Open communication is crucial in making informed decisions about your health.

Balancing Benefits and Risks: A Collaborative Approach

This research reminds us that [medication management] is a collaborative process between patients and healthcare professionals. By discussing your [medical history, lifestyle, and concerns], you can work with your doctor to create a treatment plan that balances the benefits of medication with the potential risks.

Dr.Camel's Conclusion

This study is like a desert oasis that provides a safe haven for understanding the potential benefits and risks of [fenofibrate]. By knowing the lay of the land, we can navigate the journey of medication management with greater confidence and clarity.

Date :
  1. Date Completed 1981-05-13
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

7208340

DOI: Digital Object Identifier

7208340

Related Literature

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.